CONSERVE 2021 Guidelines for Reporting Trials Modified for the COVID-19 Pandemic Creation and Adoption of Large Language Models in Medicine Global Burden of Cancer, 2010-2019 Global Burden of Long COVID Global Burden of Melanoma Global Burden of Skin Diseases, 1990-2017 Global Disparities in Parkin...
Kaczor T. An overview of melatonin and breast cancer. Natural Medicine Journal. 2010. (vol 2, issue 2):http://www.naturalmedicinejournal.com/journal/2010-02/overview-melatonin-and-breast-cancer http://www.lifeextension.com/Magazine/2004/1/report_melatonin/Page-01?p=1 Facebook Comments...
Among women in the United States, breast cancer remains the most common cancer and is the second leading cause of cancer-related deaths. The median age at diagnosis for white women is 63 years and is younger for black women at 59 years. In addition to earlier age at diagnosis, breast canc...
Cost-effectiveness in health and medicine. 1st ed. New York: Oxford University Press, 1996 Google Scholar Hillner BE, Smith TJ. Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. N Engl J Med 1991; 324: 160–8 Article PubMed CAS Google ...
Breast cancer: prevention, prediction, and treatment. 来自 Semantic Scholar 喜欢 0 阅读量: 7 作者: SM Mariani 摘要: Medscape General Medicine.关键词: Cell Line, Tumor Chromosomes, Human, Pair 17 Humans Breast Neoplasms Colorectal Neoplasms Lung Neoplasms Tamoxifen Fatty Acids, Unsaturated Anti-...
A major concern with breast cancer screening is that it increases the risk of "overdiagnosis," that is, diagnosis of cancers that would not cause noticeable disease during women's lifetimes. A 2012 study published in the journal Annals of Internal Medicine found that up to 25% of women diagno...
Cancer prevention has a profound impact on cancer-associated mortality and morbidity. We previously identified TGFβ signaling as a candidate regulator of mammary epithelial cells associated with breast cancer risk. Here, we show that short-term TGFBR in
STUDY SELECTION: Discriminatory accuracy studies of breast cancer risk assessment methods; randomized clinical trials of tamoxifen, raloxifene, and aromatase inhibitors for primary breast cancer prevention; studies of medication adverse effects. DATA EXTRACTION AND SYNTHESIS: Investigators abstracted data on me...
The Cost of Breast Cancer Screening in the Medicare Population Background: Little is known about the cost to Medicare of breast cancer screening or whether regional-level screening expenditures are associated with canc... CP Gross,JB Long,JS Ross,... - 《Jama Internal Medicine》 被引量: 74...
"It's always great to have more choices," said University of California, Los Angeles internal medicine specialist Dr. Carol M. Mangione, who chaired the panel's deliberations on breast cancer prevention drugs. Breast cancer is the most common non-skin cancer and the second-leading cause of ca...